ArticleNature medicine2019

Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma.

Rishu Agarwal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.